THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 151 filers reported holding THERAVANCE INC in Q4 2013. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $254,000 | -3.8% | 8,547 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $264,000 | -13.4% | 8,547 | 0.0% | 0.00% | -20.0% |
| Q4 2013 | $305,000 | -12.1% | 8,547 | +0.6% | 0.01% | -16.7% |
| Q3 2013 | $347,000 | +5.8% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $328,000 | +63.2% | 8,500 | 0.0% | 0.01% | +50.0% |
| Q1 2013 | $201,000 | – | 8,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
| Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
| Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
| PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
| Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
| Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
| BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |